Cite
HARVARD Citation
Sunakawa, Y. et al. (n.d.). PD-013RAS mutations in circulating tumor DNA (ctDNA) and clinical outcomes of rechallenge treatments with anti-EGFR antibodies in patients with metastatic colorectal cancer (mCRC). Annals of oncology. p. . [Online].